Stanford University
Showing 621-640 of 1,025 Results
-
Carson T. Moss
Affiliate, Department Funds
BioDr. Carson T. Moss is a Pulmonary and Critical Care Medicine fellow at Stanford University, where he completed his Internal Medicine residency training. His clinical and research program centers on pulmonary complications in immunocompromised patients, with a primary focus on bronchiolitis obliterans syndrome (BOS), a rare and often irreversible obstructive airway disease arising as a manifestation of chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic cell transplantation (HCT). To characterize disease onset and progression, his investigative work applies quantitative CT imaging and longitudinal pulmonary function metrics as non-invasive diagnostic and monitoring tools, with parallel interest in respiratory infectious complications in this population. Central to this work is an emerging focus on bronchiectasis, particularly as a co-occurring complication of BOS after HCT.
Dr. Moss has contributed to multicenter clinical trials including STOP-BOS, ATHOS-III, and PETAL-ROSE, and his original research has been published in Blood Advances and Transplantation and Cellular Therapy, with findings presented at the American Thoracic Society International Conference. He conducts clinical and translational research within the Hsu Lab, in collaboration with Dr. Joe Hsu. Dr. Moss maintains an active commitment to medical education, with leadership experience in organized medicine and mentorship of trainees across academic medicine. -
Patricia Moussatche
CTSA Hub QA/QC Project Manager, Translational Research Operations
Current Role at StanfordCTSA Hub QA/QC Program Manager
-
Kevin Nee, MD, PhD
Affiliate, Department Funds
Resident in SurgeryBioDr. Nee is a general surgery resident at Stanford, Department of Surgery. He completed his MD/PhD training at UC Irvine: School of Medicine in the Medical Scientist Training Program. His dissertation research focused on defining pericytes, fibroblasts, and adipocytes in breast cancer using single-cell RNA sequencing.
